Clinical vaccine efficacy and clinical effectiveness of oseltamivir in reducing Influenza related complications in patients with a solid organ transplant (inFLUenza in Solid Organ Transplant recipients, FLUSOT)

Clinical vaccine efficacy and clinical effectiveness of oseltamivir in reducing Influenza related complications in patients with a solid organ transplant.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON21725

Enrollment

200

Registered

2020-01-30

Start date

2020-03-01

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory virus infection in solid organ transplant recipients

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Admission in a hospital within the Leiden Transplantation Region with laboratory confirmed Influenza A or B infection or with a diagnostic test for respiratory virus infection in solid organ recipient (kidney, liver, pancreas or combination) between October 2013 and March 2020 (end of flu season 2020)

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
30 day mortality	—

Secondary

Measure	Time frame
ICU admission clinical vaccine effectiveness	—

Contacts

Public ContactGeert Groeneveld

LUMC

g.h.groeneveld@lumc.nl0715269111

Outcome results